Davidson Kempner Capital Management’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding CANO.WS
Davidson Kempner Capital Management's CANO.WS Position: Q4 2023 in Review
Davidson Kempner Capital Management sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q4 2023, closing a stake of 700,000 shares — an estimated $35K sold.
Davidson Kempner Capital Management first reported a position in CANO.WS in Q2 2021 and held it in 6 quarters. The position peaked at $563K in Q3 2022. 2 funds tracked by Wall St. Rank hold CANO.WS as of Q4 2023.
- Davidson Kempner Capital Management reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q4 2023 after selling out during the quarter.
- Davidson Kempner Capital Management sold 700,000 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q4 2023, an estimated $35K.
- Davidson Kempner Capital Management first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q2 2021 and held it in 6 quarters.
- Davidson Kempner Capital Management's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $563K in Q3 2022.
- 2 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q4 2023.
Based on Davidson Kempner Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.